| CAS: | 900305-37-5 | ||||
| 分子式: | C21H24N4O3 | ||||
| 分子量: | 380.44 | ||||
| 英文名称: |
| ||||
| 用途: | PFI-4是一种有效的选择性BRPF1 bromodomain抑制剂,IC50为80 nM。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||
| P797326 | MACKLIN | PFI-4 | 10mM in DMSO | 610元/1ml; | 展开 | ||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||
| P872488 | MACKLIN | PFI-4 | 99% | 390元/5mg; | 展开 | ||||||||||||||||||||||||||||||||||||||||
储存:-20℃ 状态:粉末 | |||||||||||||||||||||||||||||||||||||||||||||
| 2062538 | J&K | PFI-4 | 98%, 一种有效的, 渗透细胞的选择性BRPF1 Bromodoman抑制剂, IC50为 80 Nm, 作用于BRPF1比作用于其他Bromodoman (包括BRPF2/3和BRD4) 选择性强100多倍 | 618元/5MG; 827元/10MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||
基本信息
产品描述 PFI-4是一种有效的选择性BRPF1 bromodomain抑制剂,IC50为80 nM。 靶点(IC50 & Targe) BRPF1,80nM BRPF2,7.9μM BRPF3,>10μM 体外研究 PFI-4 is cell permeable, and acts by displacing the BRPF1 bromodomain from Histone H3.3. [1] 参考文献 [1] Demont EH, et al. ACS Med Chem Lett. 2014, 5(11), 1190-11 | |||||||||||||||||||||||||||||||||||||||||||||
| PZ0307 | Sigma-Aldrich | PFI-4 | ≥98% (HPLC) | 1117.23元/5 MG; 4498.97元/25 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||
产品说明 包装 5, 25 mg in glass bottle 生化/生理作用 PFI-4 is an SGC chemical probe for the bromodomains of the BRPF (BRomodomain and PHD Finger containing) scaffolding protein BRPF1B. The BRPF proteins (BRPF1/2/3) assemble histone acetyltransferase (HAT) complexes of the MYST transcriptional coactivator family members MOZ and MORF. The BRPF1 protein is the scaffold subunit of the MYST acetyltransferase complex, which plays a crucial roles in DNA repair, recombination and replication as well as transcription activation. Mutations in MOZ, MORF, and BRPF1 have all been associated with cancer. BRPF1 exists in 2 different isoforms: BRPF1A and BRPF1B. PFI-4 specifically binds to BRPF1B with a Kd =13 nM as determined by ITC. It reduces recovery time in triple BRD cell construct in FRAP and is potent in cells with IC50 250nM, while showing no effect on BRPF1A. For full characterization details, please visit the PFI-4 probe summary on the Structural Genomics Consortium (SGC) website. 特点和优势 PFI-4 is an epigenetic chemical probe available through a partnership with the Structural Genomics Consortium (SGC). To learn more and view other SGC epigenetic probes, visit sigma.com/SGC. 其他说明 This compound was developed by Pfizer for Gene Regulation research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer. 法律信息 Sold for research purposes under agreement from Pfizer Inc. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||